公司简介-Sungetide Biological Co., Ltd.

RecommendRecommend

Sungetide Won the First Prize in the Industry Final (Biomedicine) of the 16th China Shenzhen Innovation and Entrepreneurship Competition Longgang Division Qualifier & the 4th Longgang Innovation and Entrepreneurship Star Competition!
2025 J.P. Morgan Week | Sungetide Innovative Project to Debut in San Francisco
Corporate Milestone | Potential FIC Candidate! Sungetide’s Class 1 Antifungal New Drug SG1001 Completes Phase I Clinical Trial
Corporate Milestone | Breaking News! Sungetide’s Innovative Drug SG1001 Secures FDA Clinical Trial Approval, Embarking on Its Global Journey!
Corporate Announcement | Sungetide Named One of Longgang District Top 100 Emerging Enterprises, Innovative Strength Authoritatively Recognized!
Corporate Milestone | Sungetide and Livzon Pharmaceutical Announce: First Patient Dosed in Phase II Clinical Trial of Class 1 Novel Antifungal Drug SG1001

hot key wordsKeywords

contact usContact Us

Sungetide Biological Co., Ltd.

电话：xxxx-00000000

传真：xxxx-000000

邮箱：xxxxx.cn

地址：xxxxxxxxxx

资料正在整理中.....

For protecting human health, we focus on the R&D of new drugs to solve unmet clinical needs

Telephone: 0755-28967200

Email: info@sungening.com

Copyright © Sungetide Biological Co., Ltd. 粤ICP备2026014977号
Mainly engaged inOral cyclic peptide, PCSK9 inhibitor, innovative drug development, Welcome to inquire！
Technical Support：华企立方 disclaimer Article | Site map | RSS | XML

| Contact

关于我们

关于我们

RecommendRecommend

hot key wordsKeywords

contact usContact Us

Sungetide Biological Co., Ltd.